Englewood Lab Inc Cash Flow-to-Debt Ratio
Englewood Lab Inc cash flow-to-debt ratio. Englewood Lab Inc (950140) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of ₩6.76 Billion could theoretically repay 0% of its total liabilities (₩75.21 Billion) in one year. Check cash flow quality index of Englewood Lab Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Englewood Lab Inc (2015–2024)
Cash flow-to-debt ratio of Englewood Lab Inc from 2015 to 2024. Historical debt coverage capacity for Englewood Lab Inc across 10 annual periods. Check 950140 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Englewood Lab Inc Cash Flow-to-Debt Ratio by Year (2015–2024)
Englewood Lab Inc cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for Englewood Lab Inc. For the full cash flow conversion analysis, see cash flow conversion of Englewood Lab Inc.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩9.47 Million | ₩37.98 Million | ▼ -29.1% |
| 2023 | 0.35x | ₩16.01 Million | ₩45.54 Million | ▼ -99.9% |
| 2022 | 286.13x | ₩9.56 Billion | ₩33.42 Million | ▲ +266.1% |
| 2021 | -172.30x | ₩-6.86 Billion | ₩39.84 Million | ▼ -204.3% |
| 2020 | 165.26x | ₩7.30 Billion | ₩44.16 Million | ▼ -36.1% |
| 2019 | 258.73x | ₩12.12 Billion | ₩46.83 Million | ▲ +218.7% |
| 2018 | -217.92x | ₩-9.37 Billion | ₩42.99 Million | ▲ +27.3% |
| 2017 | -299.60x | ₩-8.98 Billion | ₩29.98 Million | ▼ -82360.6% |
| 2016 | -0.36x | ₩-2.90 Million | ₩7.99 Million | ▼ -529.9% |
| 2015 | -0.06x | ₩-1.13 Billion | ₩19.56 Billion | — |